Newsfile Corp
06 Jun 2026, 14:56 UTC · 4h ago
WGS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Deadline on August 3, 2026
Newsfile Corp
06 Jun 2026, 14:56 UTC · 4h ago
Story key points
4 claims · impact-rated
GeneDx cut its 2026 revenue guidance from $540-555 million down to $475-490 million. — A significant downward revision of annual guidance directly reduces earnings expectations and valuation.
-0.80GeneDx recognized a $31.3 million goodwill impairment charge on the Fabric Genomics acquisition, which it purchased for $36.5 million only a year prior. — This indicates a massive failure in M&A execution and a significant write-down of asset value.
-0.70The company's average reimbursement rate came in at $3,300, missing expectations by $200. — Lower-than-expected reimbursement rates suggest deteriorating margins and pricing pressure in the core business.
-0.50GeneDx is facing a federal securities class action lawsuit alleging misleading statements regarding Fabric Genomics and reimbursement durability. — Litigation creates legal liabilities and reputational risk, though often secondary to the fundamental financial misses.
Continue reading
6 related stories
Top 3 movers · tap to explore
Ticker attribution
Model heads
The company is facing a securities class action lawsuit following a 49% share price drop and missed financial guidance.
The company is mentioned in the context of a securities class action deadline.
The company is mentioned in the context of a securities class action deadline.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
7 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
Newsfile Corp
4h ago
